JILLIAN BUSCH: Open Payments
NPI 1053511204 · FORT COLLINS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$579 in 20 payments from 6 companies in 2025. Trend: 2023 $428 · 2024 $152 · 2025 $579
Food & beverage: $579
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $206 |
| ABBVIE INC. | 8 | $166 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $91 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| Corium, LLC | 3 | $37 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
Products named: COBENFY, VRAYLAR, CAPLYTA, REXULTI, Azstarys, FANAPT.
Industry payments across CO — which companies pay providers there.
